Opus Genetics Stock Technical Analysis
| IRD Stock | 3.64 0.00 0.00% |
As of the 16th of February 2026, Opus Genetics holds the Semi Deviation of 3.81, risk adjusted performance of 0.1755, and Coefficient Of Variation of 483.07. Opus Genetics technical analysis gives you tools to exploit past prices in attempt to determine a pattern that determines the direction of the company's future prices. Please check Opus Genetics information ratio, value at risk, as well as the relationship between the Value At Risk and expected short fall to decide if Opus Genetics is priced some-what accurately, providing market reflects its current price of 3.64 per share. Given that Opus Genetics has jensen alpha of 1.01, we recommend you to check out Opus Genetics's recent market performance to make sure the company can sustain itself at a future point.
Opus Genetics Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Opus, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to OpusOpus Genetics' Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.Opus Genetics Analyst Consensus
| Target Price | Consensus | # of Analysts | |
| 7.75 | Strong Buy | 3 | Odds |
Most Opus analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Opus stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Opus Genetics, talking to its executives and customers, or listening to Opus conference calls.
Will Pharmaceuticals sector continue expanding? Could Opus diversify its offerings? Factors like these will boost the valuation of Opus Genetics. Market participants price Opus higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Opus Genetics data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (1.86) | Revenue Per Share | Quarterly Revenue Growth (0.20) | Return On Assets | Return On Equity |
Understanding Opus Genetics requires distinguishing between market price and book value, where the latter reflects Opus's accounting equity. The concept of intrinsic value - what Opus Genetics' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Opus Genetics' price substantially above or below its fundamental value.
Please note, there is a significant difference between Opus Genetics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Opus Genetics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Opus Genetics' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Opus Genetics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Opus Genetics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Opus Genetics.
| 11/18/2025 |
| 02/16/2026 |
If you would invest 0.00 in Opus Genetics on November 18, 2025 and sell it all today you would earn a total of 0.00 from holding Opus Genetics or generate 0.0% return on investment in Opus Genetics over 90 days. Opus Genetics is related to or competes with Acumen Pharmaceuticals, Seer, Agenus, Inovio Pharmaceuticals, VistaGen Therapeutics, TuHURA Biosciences, and Alector. Opus Genetics is entity of United States More
Opus Genetics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Opus Genetics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Opus Genetics upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 4.59 | |||
| Information Ratio | 0.1934 | |||
| Maximum Drawdown | 22.4 | |||
| Value At Risk | (7.41) | |||
| Potential Upside | 9.77 |
Opus Genetics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Opus Genetics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Opus Genetics' standard deviation. In reality, there are many statistical measures that can use Opus Genetics historical prices to predict the future Opus Genetics' volatility.| Risk Adjusted Performance | 0.1755 | |||
| Jensen Alpha | 1.01 | |||
| Total Risk Alpha | 0.6704 | |||
| Sortino Ratio | 0.2162 | |||
| Treynor Ratio | 1.57 |
Opus Genetics February 16, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1755 | |||
| Market Risk Adjusted Performance | 1.58 | |||
| Mean Deviation | 3.96 | |||
| Semi Deviation | 3.81 | |||
| Downside Deviation | 4.59 | |||
| Coefficient Of Variation | 483.07 | |||
| Standard Deviation | 5.13 | |||
| Variance | 26.28 | |||
| Information Ratio | 0.1934 | |||
| Jensen Alpha | 1.01 | |||
| Total Risk Alpha | 0.6704 | |||
| Sortino Ratio | 0.2162 | |||
| Treynor Ratio | 1.57 | |||
| Maximum Drawdown | 22.4 | |||
| Value At Risk | (7.41) | |||
| Potential Upside | 9.77 | |||
| Downside Variance | 21.02 | |||
| Semi Variance | 14.48 | |||
| Expected Short fall | (4.43) | |||
| Skewness | 0.4503 | |||
| Kurtosis | 0.5686 |
Opus Genetics Backtested Returns
Opus Genetics is unstable given 3 months investment horizon. Opus Genetics maintains Sharpe Ratio (i.e., Efficiency) of 0.24, which implies the firm had a 0.24 % return per unit of risk over the last 3 months. We were able to interpolate data for twenty-seven different technical indicators, which can help you to evaluate if expected returns of 1.19% are justified by taking the suggested risk. Use Opus Genetics Risk Adjusted Performance of 0.1755, coefficient of variation of 483.07, and Semi Deviation of 3.81 to evaluate company specific risk that cannot be diversified away. Opus Genetics holds a performance score of 18 on a scale of zero to a hundred. The company holds a Beta of 0.67, which implies possible diversification benefits within a given portfolio. As returns on the market increase, Opus Genetics' returns are expected to increase less than the market. However, during the bear market, the loss of holding Opus Genetics is expected to be smaller as well. Use Opus Genetics expected short fall, and the relationship between the value at risk and rate of daily change , to analyze future returns on Opus Genetics.
Auto-correlation | 0.14 |
Insignificant predictability
Opus Genetics has insignificant predictability. Overlapping area represents the amount of predictability between Opus Genetics time series from 18th of November 2025 to 2nd of January 2026 and 2nd of January 2026 to 16th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Opus Genetics price movement. The serial correlation of 0.14 indicates that less than 14.0% of current Opus Genetics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.14 | |
| Spearman Rank Test | 0.28 | |
| Residual Average | 0.0 | |
| Price Variance | 0.27 |
Opus Genetics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Opus Genetics Technical Analysis
The output start index for this execution was one with a total number of output elements of sixty. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Opus Genetics volatility. High ATR values indicate high volatility, and low values indicate low volatility.
About Opus Genetics Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Opus Genetics on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Opus Genetics based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Opus Genetics price pattern first instead of the macroeconomic environment surrounding Opus Genetics. By analyzing Opus Genetics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Opus Genetics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Opus Genetics specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2023 | 2025 | 2026 (projected) | Interest Debt Per Share | 0.0615 | 0.0707 | 0.0672 | Revenue Per Share | 0.88 | 0.47 | 0.91 |
Opus Genetics February 16, 2026 Technical Indicators
Most technical analysis of Opus help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Opus from various momentum indicators to cycle indicators. When you analyze Opus charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1755 | |||
| Market Risk Adjusted Performance | 1.58 | |||
| Mean Deviation | 3.96 | |||
| Semi Deviation | 3.81 | |||
| Downside Deviation | 4.59 | |||
| Coefficient Of Variation | 483.07 | |||
| Standard Deviation | 5.13 | |||
| Variance | 26.28 | |||
| Information Ratio | 0.1934 | |||
| Jensen Alpha | 1.01 | |||
| Total Risk Alpha | 0.6704 | |||
| Sortino Ratio | 0.2162 | |||
| Treynor Ratio | 1.57 | |||
| Maximum Drawdown | 22.4 | |||
| Value At Risk | (7.41) | |||
| Potential Upside | 9.77 | |||
| Downside Variance | 21.02 | |||
| Semi Variance | 14.48 | |||
| Expected Short fall | (4.43) | |||
| Skewness | 0.4503 | |||
| Kurtosis | 0.5686 |
Opus Genetics February 16, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Opus stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.09 | ||
| Daily Balance Of Power | 0.00 | ||
| Rate Of Daily Change | 1.00 | ||
| Day Median Price | 3.54 | ||
| Day Typical Price | 3.57 | ||
| Price Action Indicator | 0.10 | ||
| Market Facilitation Index | 0.33 |
Complementary Tools for Opus Stock analysis
When running Opus Genetics' price analysis, check to measure Opus Genetics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Opus Genetics is operating at the current time. Most of Opus Genetics' value examination focuses on studying past and present price action to predict the probability of Opus Genetics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Opus Genetics' price. Additionally, you may evaluate how the addition of Opus Genetics to your portfolios can decrease your overall portfolio volatility.
| AI Portfolio Prophet Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |